Form 4: Calumet Director Daniel Sajkowski Granted 7,067 Restricted Stock Units

Calumet, Inc. Director Daniel J. Sajkowski was granted 7,067 Restricted Stock Units on June 11, 2025, as reported in a recent SEC Form 4 filing.

Summary

• Daniel J. Sajkowski, a Director of Calumet, Inc. (CLMT), was granted 7,067 Restricted Stock Units (RSUs).
• The transaction date for this grant was June 11, 2025.
• Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
• The RSUs will vest upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026.
• The Restricted Stock Units will be settled (converted to shares) upon vesting.
• Following this transaction, Mr. Sajkowski beneficially owns 7,067 Restricted Stock Units directly.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally a positive signal, aligning interests and showing commitment, though it's a routine compensation event rather than a major strategic announcement.

Positives

• The grant of Restricted Stock Units to a director aligns the director's interests with long-term shareholder value.
• The acquisition of equity by an insider can be viewed as a positive signal of confidence in the company's future.

Future Outlook

The vesting schedule for the granted Restricted Stock Units indicates a future conversion to common stock, aligning the director's long-term incentives with the company's performance through at least June 2026.

Industry Context

The grant of Restricted Stock Units to a director is a common practice in corporate compensation structures across various industries, aiming to align executive and board member interests with long-term shareholder value. This practice is standard for publicly traded companies like Calumet, Inc. to incentivize retention and performance.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of director compensation is a widely adopted practice across U.S. public companies, including those in the energy or specialty chemicals sector where Calumet, Inc. operates.
• This method is favored for its ability to align director incentives with long-term shareholder value, as the value of the compensation is tied directly to the company's stock performance.
• While specific grant sizes vary based on company size, industry, and individual responsibilities, a grant of 7,067 RSUs to a director is within typical ranges for companies of similar market capitalization and industry, comparable to compensation practices seen at peers like HollyFrontier Corporation (HFC) or Valero Energy Corporation (VLO) for their non-executive directors, though exact figures would require detailed compensation peer group analysis.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially fostering better long-term performance and governance.

Next Steps

• Vesting of the 7,067 Restricted Stock Units on the earlier of June 11, 2026, or the 2026 Annual Meeting.
• Settlement of the Restricted Stock Units into common stock upon vesting.

Key Dates

Recommendation

Keywords

Calumet Inc., CLMT, SEC Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant